Abstract Review Committee
Introducing the Abstract Review Committee for the upcoming 5th High Level Ministerial Meeting on Antimicrobial Resistance.
Abstract submission results will be announced on April 23,2026.
Seye Abimbola is a professor at the School of Public Health, University of Sydney, Australia. He has lectured, researched, and written extensively on learning and governance in health systems and on knowledge practices and epistemic injustice in global health.
He was awarded the 2020-22 Prince Claus Chair in Equity and Development at Utrecht University in the Netherlands for his work on justice in health research, and was the 2023-24 Radulovacki Visiting Professor in Global Health Studies at Northwestern University in the United States. His book, a collection of essays titled "The Foreign Gaze" was published in 2024, and is being translated into multiple languages. He was the founding editor in chief (2015-2024) of BMJ Global Health.
Professor Seye Abimbola
Professor, School of Public Health, University of Sydney, Australia
Dr Selina Namchee Lo
Executive Director, Australian Global Health Alliance Consulting Editor, The Lancet
Dr Lo has nearly three decades experience in global and international health with qualifications in medicine (University of Melbourne), tropical medicine (London School of Hygiene and Tropical Medicine) and a Masters in Public and International Law (University of Melbourne).
She is currently also Consulting Editor (Global and Planetary Health Commissions) for The Lancet medical journal where she was previous Senior Editor based in London and Beijing. She has been handling editor of a number of global health peer reviewed commissions including the Rockefeller Lancet Planetary Health report, the first Lancet series on Transgender Health and Global Health 2035: Investing in Health. She has also worked as a Deputy Editor for the Medical Journal of Australia.
Associate Professor Adam Kamradt-Scott is currently the inaugural Cummings Foundation Professor of One Health Diplomacy at the Fletcher School of Law and Diplomacy, Tufts University. His research, teaching, and policy engagement work explores how governments and multilateral organisations respond to adverse health events such as epidemics, pandemics, and emerging health and security challenges.
Prior to entering academia, Professor Kamradt-Scott’s background includes having worked as a health professional specialising in emergency care and clinical risk management, a political and legislative adviser, and a public servant in national pandemic preparedness. Before joining Tufts University, he worked at the London School of Hygiene & Tropical Medicine, the University of Sydney, the European University Institute, and the Harvard T.H Chan School of Public Health. Professor Kamradt-Scott holds formal academic qualifications in health, international relations, and law, and has published three books and over 55 journal articles and book chapters. More recently, Professor Kamradt-Scott served as an adviser to the World Bank on pandemic preparedness, as well as counselling the Australian Government on the COVID-19 response, proposed changes to the International Health Regulations, and the negotiation and adoption of the WHO Pandemic Agreement.
Professor Kamradt-Scott founded the Global Health Security conferences and served as the conference convenor from 2019-2025.
Professor Adam Karamdt-Scott
Cummings Foundation Professor of One Health Diplomacy at the Fletcher School of Law and Diplomacy, Tufts University
Ayomide Olorunfemi is a clinical research professional at the Clinical Trials Unit, Imperial College London, specialising in real-world data, regulatory compliance, study start-up, and trial delivery across the biotech and pharmaceutical sectors.
She works at the intersection of science and operations — bringing structure to complex studies, collaborating across teams, and helping move innovative treatments closer to patients, all while maintaining high-quality delivery in line with global clinical standards.
Ayomide Olorunfemi
Clinical Researcher, Imperial College London
Dr Chioma Achi
Assistant Professor, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine.
Dr Chioma Achi is an Assistant Professor with the Department of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) and a key member of the United Kingdom - Rapid Support Team (UK-PHRST) jointly run by the UK Health Security Agency (UKHSA) and LSHTM, where she coordinates the UK-PHRST multi-partnership projects on mpox.
She is also Scientific Lead for Nigeria on the University of Oxford, Ineos Oxford Institute (IOI)’s research programme on the global surveillance of AMR. During her time as a Consultant on a World Bank AMR project, she developed evidence reviews and implementation case studies for selected African countries on the World Bank's One Health operational framework for addressing AMR.
Dr Achi's research interests include AMR, One Health, infectious diseases, zoonoses, diseases of epidemic/pandemic importance, and research investigating the public health impact of climate change.
She holds a PhD in Veterinary Medicine from the University of Cambridge, an MSc in Applied Microbiology and Biotechnology from the University of Westminster London, and a Doctor of Veterinary Medicine (DVM) degree from Ahmadu Bello University, Zaria, Nigeria.
Call for Abstracts
DEADLINE: Now CLOSED
Theme: One Health - Advancing Global AMR Commitments through Local Action
The 5th High Level Ministerial on Antimicrobial Resistance invites abstract submissions for the upcoming conference in June 2026.
The overarching theme, “One Health: Advancing Global AMR Commitments through Local Action”, reflects the urgent need to:
Translate global ambitions into outcomes for people, animals and the environment
Focus especially on LMICs, where gaps in access and capacity remain most severe
Center action, equity, innovation and environmental sustainability
The conference will place particular emphasis on:
Tracking implementation of existing commitments and ensuring accountability
Addressing persistent gaps in access to antimicrobials, diagnostics and preventive measures in LMICs
Promoting forward looking tools, sustainable financing mechanisms and inclusive leadership to drive long term progress
We welcome abstracts that:
Present evidence, tools or approaches that advance national and subnational AMR responses
Document implementation of commitments made at previous High Level Ministerial meetings or through global agreements
Highlight innovations that improve access, stewardship, prevention, governance or financing in LMIC settings
Bring forward voices from communities, civil society, youth, professional associations and the private sector
Both completed work and promising initiatives at an advanced planning or early implementation stage are eligible, as long as they show clear pathways to impact.
Submissions should clearly indicate how the work contributes to one or more of the thematic areas described below and how lessons can be adapted or scaled across settings.
Submission Guidelines
Please ensure that your abstract:
Clearly states the objective, methods, key findings and implications for policy and practice
Indicates which thematic area(s) it addresses
Highlights relevance for LMICs and One Health implementation where applicable
Stays within the word limit and formatting requirements specified by the conference secretariat
Selection Criteria
Abstracts will be reviewed based on:
Relevance to the conference theme and one or more of the three thematic areas
Scientific and technical quality
Feasibility and potential for real world impact, especially in LMICs
Innovation, equity focus and inclusion of marginalized or under represented groups
Potential to inform policy, scale up or cross country learning
Please submit all abstracts by March 10, 2026 to info@5thhighlevelministerialng.com - please find the abstract guidelines linked here.